Neurotoxic effects of ketamine and different doses of ropivacaine administered intrathecally in rabbits

Basit Öğe Kaydı
dc.contributor.authorSezen, Gülbin
dc.contributor.authorDemiraran, Yavuz
dc.contributor.authorGüven, Aysel
dc.contributor.authorAnkarali, Handan
dc.contributor.authorSevinç, Özdemir
dc.contributor.authorKaragöz, Ibrahim
dc.date.accessioned2025-01-27T19:02:27Z
dc.date.available2025-01-27T19:02:27Z
dc.date.issued2013
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractObjective: Although a variety of anesthetic medicines are used intrathecally, experimental neurotoxic studies on these drugs are not sufficient. In our study, we used immunocytochemical examination to assess the neurotoxic potential of ketamine and different doses of ropivacaine administered intrathecally. Material and Methods: Thirty rabbits were divided into five groups which were inserted spinal catheters under anesthesia. Each group received in a volume of 0.3 ml, as follows: the R0.2 group received 0.2% ropivacaine, the R0.75 group received 0.75% ropivacaine, the R1 group received 1.0% ropivacaine, the K group received preservative-free S (+) ketamine and the C group received 0.9% NaCl. The onset and duration of action were recorded by using Motor Dysfunction Index (MDI). Rabbits were observed for five days and then euthanasized. After catheters were removed, brains and spinal tissue samples were evaluated by light microscopy and immunocytochemical examination. Results: The longest onset of action was observed in the K group. Among the ropivacaine groups, the onset of action diminished and the duration of action extended with an increase in dose significantly. There was axonal degeneration in the R1 group, but this finding not reach significance. In the ketamine group, significant neuronal degeneration and reduction in number of neurons in the brain sections were observed. In the 1% ropivacaine group, a relative increase in neurofilament intensity was detected using immunocytochemical assessments in the medulla spinalis and brain sections. Conclusion: The intrathecal applications of 1% ropivacaine and ketamine can induce neurotoxic damage, despite a lack of observed functional neurologic deficits. © 2013 by Türkiye Klinikleri.
dc.identifier.doi10.5336/medsci.2012-32801
dc.identifier.endpage1111
dc.identifier.issn1300-0292
dc.identifier.issue4
dc.identifier.scopus2-s2.0-84884693074
dc.identifier.scopusqualityQ4
dc.identifier.startpage1103
dc.identifier.urihttps://doi.org/10.5336/medsci.2012-32801
dc.identifier.urihttps://hdl.handle.net/20.500.12428/13495
dc.identifier.volume33
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherTurkiye Klinikleri
dc.relation.ispartofTurkiye Klinikleri Journal of Medical Sciences
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_Scopus_20250125
dc.subjectInjections; Ketamine; Ropivacaine; Spinal
dc.titleNeurotoxic effects of ketamine and different doses of ropivacaine administered intrathecally in rabbits
dc.title.alternativeTavşanlarda İntratekal uygulanan ketamin ve farkli{dotless} dozlarda ropivakainin nörotoksik etkileri
dc.typeArticle

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu